Recent selected publications supported by Schain Research
Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
Schain F et al. Transfus Apher Sci. March 21:103705. 2023.
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
Novitzky-Basso I et al. PLoS One. March 9;18(3). 2023.
Privacy preserving survival prediction
Fedeli S et al. Institue of Electrical and Electronics Engineers (IEEE) Big Data, 13 January 2022.
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. Scand J Urol. June 7:1-8. 2021.
HRU and sickness absence in newly diagnosed multiple myeloma patients who did not undergo HSCT: Trends in Sweden with the changing treatment landscape
Borgsten F et al. Eur J Hematol. 5 May. 2021.
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain F et al. Eur J Health Econ. 1 March. 2021.
Real-world data on autologous stem cell transplantation in older patients with multiple myeloma
Schain F et al. Annals of Hematology. 20 December. 2020.
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M et al. Scand J Urol. 4 April. 2020.
Survival outcomes in myelofibrosis patients treated with ruxolitinib: a population-based cohort study in Sweden and Norway
Schain F et al. European Journal of Haematology, 103(6), 614–619. December. 2019.
Recent selected conference abstracts supported by Schain Research
Treatment pattern characterization and outcomes in chronic graft versus host disease patients treated with extracorporeal photopheresis in clinical practise in Sweden
Schain F et al. Bone Marrow Transplant 22 March 2022.
Characteristics, treatment patterns and predictors of outcomes in treatment-naive acute myeloid leukemia patients judged ineligible for intensive chemotherapy in Sweden
Schain F et al. Myeloma and Leukemia, 1 September 2021.
Healthcare resource utilization and sickness absence in newly diagnosed multiple myeloma patients in Sweden: Trends in a changing treatment landscape
Borgsten F et al. American Society of Hematology. 5 December 2020.
Survival outcomes in patients with colorectal cancer in Sweden – A population based retrospective registry study
Pasquali L et al. Value in Health. 16 November 2020.
Patient characterization and survival outcomes in pediatric chronic graft versus host disease patients: a population-based study in Sweden
Schain F et al. Bone Marrow Transplant. 1 September 2020.
Real-world treatment patterns in patients with castration-resistant prostate cancer
Vigneswaran HT et al. J Clin Oncol. 20 May 2020.
Clinical outcomes and economic burden for bladder cancer patients: an analysis from a Swedish cancer registry
Bellmunt J et al. J Clin Oncol. 1 April 2020.